Ultragenyx Japan K.K. is the Japanese subsidiary of Ultragenyx Pharmaceutical Inc. (USA). It develops and brings to market therapies for rare and ultra-rare genetic diseases, serving patient populations with few or no treatment options.
Aucun commentaire disponible.
Laissez votre note & commentaire